MSB 2.22% $1.15 mesoblast limited

Ann: Ethics Approval to Treat COVID-19 Patients in Australia, page-257

  1. 107 Posts.
    lightbulb Created with Sketch. 83

    Did you read all the previous posts on this thread? There's plenty of well reasoned explanations of both:

    - the benefits of extending the trial to Australia

    - why the timing of this announcement says nothing about trial progress to date

    Why worry and stoke more worry based on feelings when evidence and logic is here to be seen?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
0.025(2.22%)
Mkt cap ! $1.313B
Open High Low Value Volume
$1.16 $1.19 $1.13 $8.289M 7.186M

Buyers (Bids)

No. Vol. Price($)
1 22569 $1.14
 

Sellers (Offers)

Price($) Vol. No.
$1.15 105374 2
View Market Depth
Last trade - 16.10pm 22/05/2024 (20 minute delay) ?
Last
$1.15
  Change
0.025 ( 2.46 %)
Open High Low Volume
$1.16 $1.19 $1.13 1229288
Last updated 15.59pm 22/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.